Strata Oncology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 82

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6.15M

  • Investors
  • 14

Strata Oncology General Information

Description

Operator of an oncology company intended to accelerate the impact of precision medicine for patients with cancer. The company partners with major healthcare systems across the country, which systematically send their cancer patients' biopsies to high-throughput CLIA labs for genomic sequencing, with results provided to the oncologist within days, indicating the tumor profile, and matching appropriate therapies and drug trials, enabling healthcare providers to provide actionable insight to the lives of cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8192 Jackson Road
  • Suite A
  • Ann Arbor, MI 48103
  • United States
+1 (833)
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 8192 Jackson Road
  • Suite A
  • Ann Arbor, MI 48103
  • United States
+1 (833)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Strata Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 22-Nov-2024 $6.15M Completed Generating Revenue
3. Later Stage VC (Series C) 28-Jul-2021 Completed Generating Revenue
2. Early Stage VC (Series B) 23-May-2018 $26M $38M Completed Generating Revenue
1. Early Stage VC (Series A) 02-Jun-2016 $12M $12M Completed Startup
To view Strata Oncology’s complete valuation and funding history, request access »

Strata Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series C-1
Series B 2,625,918 $0.000010 8% $9.9 $9.9 1x $9.9 22.34%
Series A 3,054,529 $0.000010 8% $4.04 $4.04 1x $4.04 25.99%
To view Strata Oncology’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Strata Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an oncology company intended to accelerate the impact of precision medicine for patients with cancer. The co
Decision/Risk Analysis
Ann Arbor, MI
82 As of 2023

Minneapolis, MN
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Strata Oncology Competitors (23)

One of Strata Oncology’s 23 competitors is Advanced Cell Diagnostics, a Formerly VC-backed company based in Minneapolis, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Advanced Cell Diagnostics Formerly VC-backed Minneapolis, MN
Foundation Medicine Formerly VC-backed Boston, MA
GeneCast Biotechnology Private Equity-Backed Wuxi, China
Empire Genomics Formerly PE-Backed Depew, NY
Cardiff Oncology Formerly Angel backed San Diego, CA
You’re viewing 5 of 23 competitors. Get the full list »

Strata Oncology Patents

Strata Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023383478-A1 Methods of determining cancer therapy effectiveness Pending 17-Nov-2022
EP-4619754-A2 Methods of determining cancer therapy effectiveness Pending 17-Nov-2022
US-20260193716-A1 Methods of determining cancer therapy effectiveness Pending 17-Nov-2022
WO-2024108174-A2 Methods of determining cancer therapy effectiveness Inactive 17-Nov-2022
WO-2024108174-A3 Methods of determining cancer therapy effectiveness Inactive 17-Nov-2022 G16H20/10
To view Strata Oncology’s complete patent history, request access »

Strata Oncology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Strata Oncology Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cormorant Asset Management PE/Buyout Minority
Highside Capital Management Hedge Fund Minority
Angel (individual) Minority
Monashee Investment Management Hedge Fund Minority
Revelation Partners Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Strata Oncology FAQs

  • When was Strata Oncology founded?

    Strata Oncology was founded in 2015.

  • Where is Strata Oncology headquartered?

    Strata Oncology is headquartered in Ann Arbor, MI.

  • What is the size of Strata Oncology?

    Strata Oncology has 82 total employees.

  • What industry is Strata Oncology in?

    Strata Oncology’s primary industry is Decision/Risk Analysis.

  • Is Strata Oncology a private or public company?

    Strata Oncology is a Private company.

  • What is Strata Oncology’s current revenue?

    The current revenue for Strata Oncology is .

  • How much funding has Strata Oncology raised over time?

    Strata Oncology has raised $134M.

  • Who are Strata Oncology’s investors?

    Cormorant Asset Management, Highside Capital Management, , Monashee Investment Management, and Revelation Partners are 5 of 14 investors who have invested in Strata Oncology.

  • Who are Strata Oncology’s competitors?

    Advanced Cell Diagnostics, Foundation Medicine, GeneCast Biotechnology, Empire Genomics, and Cardiff Oncology are some of the 23 competitors of Strata Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process